Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Statins use and prostate cancer mortality.

Lai SW, Kuo YH, Liao KF.

Eur J Cancer. 2020 Jan;124:219-220. doi: 10.1016/j.ejca.2019.09.017. Epub 2019 Oct 31. No abstract available.

PMID:
31677944
2.

Use of statins and the risk of death in patients with prostate cancer.

Yu O, Eberg M, Benayoun S, Aprikian A, Batist G, Suissa S, Azoulay L.

J Clin Oncol. 2014 Jan 1;32(1):5-11. doi: 10.1200/JCO.2013.49.4757. Epub 2013 Nov 4.

PMID:
24190110
3.

Mortality associated with statins in men with advanced prostate cancer treated with androgen deprivation therapy.

Wu SY, Fang SC, Shih HJ, Wen YC, Shao YJ.

Eur J Cancer. 2019 May;112:109-117. doi: 10.1016/j.ejca.2018.11.032. Epub 2019 Feb 28.

PMID:
30827745
4.

Statins induce cell apoptosis through a modulation of AKT/FOXO1 pathway in prostate cancer cells.

Deng JL, Zhang R, Zeng Y, Zhu YS, Wang G.

Cancer Manag Res. 2019 Jul 31;11:7231-7242. doi: 10.2147/CMAR.S212643. eCollection 2019.

5.

Statin and metformin therapy in prostate cancer patients with hyperlipidemia who underwent radiotherapy: a population-based cohort study.

Li K, Si-Tu J, Qiu J, Lu L, Mao Y, Zeng H, Chen M, Lai C, Chang HJ, Wang D.

Cancer Manag Res. 2019 Feb 4;11:1189-1197. doi: 10.2147/CMAR.S166638. eCollection 2019.

6.

Statin use and mortality of patients with prostate cancer: a meta-analysis.

Meng Y, Liao YB, Xu P, Wei WR, Wang J.

Onco Targets Ther. 2016 Mar 21;9:1689-96. doi: 10.2147/OTT.S97993. eCollection 2016.

7.

Statin Use in Prostate Cancer: An Update.

Babcook MA, Joshi A, Montellano JA, Shankar E, Gupta S.

Nutr Metab Insights. 2016 Jul 14;9:43-50. doi: 10.4137/NMI.S38362. eCollection 2016. Review.

8.

Biologic and epidemiologic evidence assessing if statins prevent prostate cancer.

Dawe DE, Mahmud S.

Can J Urol. 2017 Dec;24(6):9081-9088. Review.

PMID:
29260632
9.

Statin Use Reduces Prostate Cancer All-Cause Mortality: A Nationwide Population-Based Cohort Study.

Sun LM, Lin MC, Lin CL, Chang SN, Liang JA, Lin IC, Kao CH.

Medicine (Baltimore). 2015 Sep;94(39):e1644. doi: 10.1097/MD.0000000000001644.

10.

Statins and prostate cancer: molecular and clinical aspects.

Papadopoulos G, Delakas D, Nakopoulou L, Kassimatis T.

Eur J Cancer. 2011 Apr;47(6):819-30. doi: 10.1016/j.ejca.2011.01.005. Epub 2011 Feb 25. Review.

PMID:
21354784
11.

The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis.

Tan P, Wei S, Yang L, Tang Z, Cao D, Liu L, Lei J, Fan Y, Gao L, Wei Q.

Sci Rep. 2016 Jul 7;6:29106. doi: 10.1038/srep29106. Review.

12.

Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis.

Park HS, Schoenfeld JD, Mailhot RB, Shive M, Hartman RI, Ogembo R, Mucci LA.

Ann Oncol. 2013 Jun;24(6):1427-34. doi: 10.1093/annonc/mdt077. Epub 2013 Mar 18. Review.

13.

Statins and prostate cancer prevention: where we are now, and future directions.

Murtola TJ, Visakorpi T, Lahtela J, Syvälä H, Tammela TLj.

Nat Clin Pract Urol. 2008 Jul;5(7):376-87. doi: 10.1038/ncpuro1146. Epub 2008 Jun 10. Review.

PMID:
18542103
14.

Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins.

Furuya Y, Sekine Y, Kato H, Miyazawa Y, Koike H, Suzuki K.

Prostate Int. 2016 Jun;4(2):56-60. doi: 10.1016/j.prnil.2016.02.003. Epub 2016 Mar 4.

15.

Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.

Chao C, Jacobsen SJ, Xu L, Wallner LP, Porter KR, Williams SG.

BJU Int. 2013 May;111(6):954-62. doi: 10.1111/j.1464-410X.2012.11639.x. Epub 2013 Mar 6.

16.

Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review.

Tan P, Zhang C, Wei SY, Tang Z, Gao L, Yang L, Wei Q.

Asian J Androl. 2017 Nov-Dec;19(6):666-671. doi: 10.4103/1008-682X.190327. Review.

17.

Clinical Potential of Statins in Prostate Cancer Radiation Therapy.

Hutchinson J, Marignol L.

Anticancer Res. 2017 Oct;37(10):5363-5372. Review.

PMID:
28982844
18.

Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.

Raval AD, Thakker D, Negi H, Vyas A, Kaur H, Salkini MW.

Prostate Cancer Prostatic Dis. 2016 Jun;19(2):151-62. doi: 10.1038/pcan.2015.58. Epub 2016 Jan 19. Review. Erratum in: Prostate Cancer Prostatic Dis. 2016 Jun;19(2):222. Kaur, H [added].

PMID:
26782711
19.

Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Murtola TJ, Peltomaa AI, Talala K, Määttänen L, Taari K, Tammela TLJ, Auvinen A.

Eur Urol Focus. 2017 Apr;3(2-3):212-220. doi: 10.1016/j.euf.2016.05.004. Epub 2016 Jun 2.

PMID:
28753762
20.

Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins.

Vainio P, Lehtinen L, Mirtti T, Hilvo M, Seppänen-Laakso T, Virtanen J, Sankila A, Nordling S, Lundin J, Rannikko A, Orešič M, Kallioniemi O, Iljin K.

Oncotarget. 2011 Dec;2(12):1176-90.

Supplemental Content

Support Center